|
Etiology
In this study the etiology of URI was
as follows:
-
Viral etiology - 69%
-
Rhinoviruses - 52%
-
Coronavirus OC43 or 229E infection - 8%
-
Influenza A or B virus - 6%
-
Parainfluenza virus, respiratory syncytial
virus, adenovirus, enterovirus (total of single infections of each) - 7%
-
Bacterial etiology - 3.5%
-
Chlamydia pneumoniae - 2%
-
Haemophilus influenzae - 0.5%
-
Streptococcus pneumoniae - 0.5%
-
Mycoplasma pneumoniae - 0.5%
-
Undetermined etiology - 27.5%
(Includes some multiple etiologies).
-
Caveats
-
Age group: Young adults
-
Type/size: Population study of 200 patients
-
Population characteristics: Patients with
URI symptoms
-
Outcome measure: Results of virus culture,
antigen detection, PCR and serology with paired samples
-
Diagnostic criteria for URI unclear
-
Not EBM, but interesting
-
Citations
Epidemiology
No evidence is cited.
Diagnosis
No evidence is cited.
Treatment
Antibiotics
Patients who had URI symptoms and positive
nasopharyngeal cultures for H. influenzae, M. catarrhalis, or S.
pneumoniae reported higher cure rates after amoxicillin-clavulanate.
Patients who had negative cultures did not report any benefits from amoxicillin-clavulanate.
-
Caveats
-
Age group: Adults
-
Type/size: RCT of 314
-
Outcome measure: Symptom improvement
-
Patients who came to an infectious disease
clinic; may not apply to primary care clinics
-
Other antibiotics not studied
-
Citations
Antibiotics used to treat URIs do not
prevent subsequent pneumonia.
-
Caveats
-
Age group studied: Young children
-
Type/size: Meta-analysis
-
Outcome measure: Prevention of pneumonia,
not effect on URI symptom intensity or duration
-
Citations
Receiving a prescription for an antibiotic
for a URI was not associated with increased patient satisfaction. Better
to spend time explaining the nature of a particular illness and the physician's
choice of treatment.
-
Caveats
-
Age group: Adults
-
Type/size: RCT of 113
-
Outcome measure: Patient satisfaction
-
Diagnostic criteria unclear
-
Citations
Decongestants/Antihistamines
Chlorpheniramine maleate, pseudoephedrine
hydrochloride, oxymetazoline hydrochloride, phenylpropanolamine
hydrochloride, ipratropium bromide, and atropine methonitrate,
alone and combined with antihistamines, can improve URI symptoms
in adults.
-
Caveats
-
Age group: Adults
-
Type/size: Meta-analysis (19 studies)
-
Outcome measure: Symptom relief
-
Citations
Antihistamines alone probably do not
improve symptoms of URIs, and frequently cause somnolence.
-
Caveats
-
Age group: Adults
-
Type/size: Meta-analysis (7 studies - often
weak)
-
Outcome measure: Symptom relief
Other Treatments
Ipratropium bromide nasal spray
may offer some minor benefit, although the response may actually be due
to the saline vehicle.
-
Caveats
-
Age group: Adults
-
Type/size: RTC of 411
-
Outcome measure: Symptom relief
-
Citations
Zinc salts lozenges do not reduce the
duration of common
colds.
-
Caveats
-
Age group: Unclear
-
Type/size: Meta-analysis (6 studies)
-
Population: Patients with naturally-occuring
colds
-
Outcome measure: Duration of symptoms
-
Citations
Vitamin C, in doses of a gram or more
per day, showed a consistently beneficial but generally modest therapeutic
effect on duration of URI symptoms (a little less than 0.5 of a symptom
day per URI episode).
-
Caveats
-
Age group: Adults
-
Type/size: Meta-analysis (30 trials)
-
Outcome measure: Duration of symptoms
-
Best dosage is not clear
Monitoring
No evidence is cited.
Prognosis
No evidence is cited.
Prevention
Vitamin C, taken prophylactically
even in doses of one or more grams daily for several winter months, had
no consistent beneficial effect on incidence of URIs.
-
Caveats
-
Age group: Adults
-
Type/size: Meta-analysis (30 trials)
-
Outcome measure: Reduction of incidence of
URIs
Patient Education
The following patient education materials
are consistent with the available evidence.
Rev. 10/20/01
|